Latest Development Activity News

Entropy Neurodynamics has received a $1.73 million R&D tax incentive refund from the Australian Government, reinforcing its clinical development of an intravenous psilocin treatment for neuropsychiatric disorders.

GoldArc Resources has kicked off a comprehensive 34,000-metre grade control drilling campaign at its Mt Stirling gold deposit, aiming to sharpen resource estimates and pave the way for mining operations.

Variscan Mines updates the market on earn-in negotiations for its Irish Zinc assets, clarifying no defaults by partners and signalling a revised timeline for key agreement conditions.

Freehill Mining has raised $1.5 million through a discounted share placement to fund exploration of copper-gold projects in Chile and expand its processing capacity.

Breakthrough Minerals has announced a focused drilling campaign at its Barbara Copper-Gold Project in Queensland, aiming to expand its substantial copper-gold resource within the broader Queensland Copper-Gold Project portfolio.

Brightstar Resources has successfully upsized its Share Purchase Plan to $18 million, raising total equity proceeds of $193 million to fully fund its Goldfields Project and accelerate development at Sandstone.

Maronan Metals has been granted a Mineral Development Licence for its Maronan Silver Project, marking a pivotal step toward mine readiness and enabling underground resource expansion.

Variscan Mines has announced a delay in its earn-in agreement for Irish zinc assets after vendors failed to meet financial obligations within the agreed timeframe. The company’s board will now reassess next steps amid growing uncertainty.

Lion Rock Minerals announces a leadership transition as CEO Casper Adson steps into a technical advisory role, with the Board seeking a new CEO to strengthen on-ground presence and accelerate exploration at the Minta Project in Cameroon.

Nexalis Therapeutics reported a widening loss of $1.83 million for 2025, reflecting increased investment in product development and marketing. Despite the loss, the company boosted its cash reserves through equity raises and borrowings.

Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.

Terra Metals has raised $85 million through an institutional placement to fast-track exploration and development of its promising Southwest Prospect within the Dante Project in Western Australia.